MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Modified Timed Up and Go test as a marker for motor improvement in advanced Parkinson’s disease after in-patient multimodal intensive neurorehabilitation and care

M. Mccrossin, F. Avantaggiato, E. Cipparonne, L. Rubin, A. Di Rocco (Glen Cove, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Rehabilitation, Timed Up and Go test

Category: Allied Healthcare: Physical Therapy, Speech Therapy, Rehabilitation (will be presented in Parkinson's Disease (Other) category

Objective: To determine if a modified Timed Up and Go (TUG) test can be used to monitor motor improvement in patients with Parkinson’s disease (PD) dependent on ambulatory assistance during a 2-week in-patient multimodal intensive neurorehabilitation and care (i-MINC) stay.

Background: The TUG test is a widely used measure of functional mobility in the elderly and PD population. Its use is generally limited to patients able to walk independently.

Method: 76 PD patients (H&Y stage ≥3) were included. All required an assistive device and/or hands-on assistance on admission to i-MINC. They were assessed in their best ON state with a UPDRS examination and a modified TUG test allowing for ambulatory assistance at admission and prior to discharge. A paired T-test was used to analyze changes in TUG completion time and UPDRS scores, and a Wilcoxon signed-rank test for changes in TUG level of assistance (Table 1). The type of assistive device used during the test was recorded.

Results: 75 out of 76 patients showed improvement in TUG completion time. 76 patients improved in UPDRS total and motor scores. The average improvement in TUG completion time was 12.88 secs (p<0.0001), paralleled by a 16.84-point improvement in UPDRS total score and 6.41-point improvement in UPDRS motor score (p<0.0001). 79% of patients required a reduced level of assistance at discharge (p<0.0001). Only 8 patients required a more restrictive assistive device.

Conclusion: This study highlights the effectiveness of a modified TUG test as a marker for motor improvement in PD patients undergoing i-MINC. The joint reduction in TUG completion times, UPDRS total and motor scores strongly suggests that the modified test is a reliable and sensitive measure of motor function changes. Moreover, improvements in the level of assistance required during the test support the conclusion that i-MINC positively impacted functional mobility in the majority of patients. Adapting the TUG to accommodate patients dependent on ambulatory assistance creates a more inclusive assessment standard that can be used across the PD severity spectrum. Future studies may focus on formal reliability evaluation and application of the modified TUG test in other rehabilitation settings.

Table 1

Table 1

References: Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P.,Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., LeWitt, P. A., Nyenhuis, D., … LaPelle, N. (2008). Movement disorder society‐sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS‐UPDRS): Scale presentation and Clinimetric testing results. Movement Disorders, 23(15), 2129–2170. https://doi.org/10.1002/mds.22340

Moondra, P., Rubin, L., McCrossin, M., Persaud, A., Di Rocco, A., Quartarone, A., & Ghilardi, M. F. (2024). In-Patient Multimodal Intensive Neurorehabilitation and Care Improve Motor and Non-Motor Functions in the Moderately Advanced Stages of Parkinson’s Disease: A Retrospective Study in a U.S. Facility. Biomedicines, 12(8), 1658. https://doi.org/10.3390/biomedicines12081658

Podsiadlo, D. and Richardson, S. (1991). “The timed “Up & Go”: a test of basic functional mobility for frail elderly persons.” J Am Geriatr Soc 39(2): 142-148.

To cite this abstract in AMA style:

M. Mccrossin, F. Avantaggiato, E. Cipparonne, L. Rubin, A. Di Rocco. Modified Timed Up and Go test as a marker for motor improvement in advanced Parkinson’s disease after in-patient multimodal intensive neurorehabilitation and care [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/modified-timed-up-and-go-test-as-a-marker-for-motor-improvement-in-advanced-parkinsons-disease-after-in-patient-multimodal-intensive-neurorehabilitation-and-care/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/modified-timed-up-and-go-test-as-a-marker-for-motor-improvement-in-advanced-parkinsons-disease-after-in-patient-multimodal-intensive-neurorehabilitation-and-care/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley